Intracerebral hemorrhage after pipeline embolization: Management of antiplatelet agents and the case for point-of-care testing--case reports and review of literature

Clin Neurol Neurosurg. 2014 Sep:124:21-4. doi: 10.1016/j.clineuro.2014.06.021. Epub 2014 Jun 25.

Authors

Nohra Chalouhi¹, Mario Zanaty², Pascal M Jabbour², Robert M Starke³, Stavropoula I Tjoumakaris², Robert H Rosenwasser², L Fernando Gonzalez²

Affiliations

¹ Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, USA. Electronic address: nohra.chalouhi@jefferson.edu.
² Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, USA.
³ Department of Neurological Surgery, University of Virginia, Charlottesville, USA.

PMID: 24999277
DOI: 10.1016/j.clineuro.2014.06.021

No abstract available

Keywords: Flow diversion; Intracerebral hemorrhage; Pipeline embolization device; Platelet.

Publication types

Case Reports
Review

MeSH terms

Aspirin / administration & dosage*
Cerebral Hemorrhage / drug therapy
Cerebral Hemorrhage / etiology
Cerebral Hemorrhage / therapy*
Clinical Protocols*
Clopidogrel
Drug Administration Schedule
Embolization, Therapeutic / adverse effects*
Embolization, Therapeutic / instrumentation
Humans
Middle Aged
Platelet Aggregation Inhibitors / administration & dosage*
Platelet Transfusion / methods*
Receptors, Purinergic P2Y12 / analysis*
Ticlopidine / administration & dosage
Ticlopidine / analogs & derivatives*

Substances

P2RY12 protein, human
Platelet Aggregation Inhibitors
Receptors, Purinergic P2Y12
Clopidogrel
Ticlopidine
Aspirin